Oxygen‐Evolving Manganese Ferrite Nanovesicles for Hypoxia‐Responsive Drug Delivery and Enhanced Cancer Chemoimmunotherapy-Reference-Cited by-同舟云学术

Oxygen‐Evolving Manganese Ferrite Nanovesicles for Hypoxia‐Responsive Drug Delivery and Enhanced Cancer Chemoimmunotherapy

Published:2021-01-20 Issue:11 Volume:31 Page:2008078
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Yang Kuikun¹²,Yu Guocan²,Tian Rui²,Zhou Zijian²,Deng Hongzhang²,Li Ling²,Yang Zhen²,Zhang Guofeng²,Liu Dahai²,Wei Jianwen¹,Yue Ludan¹,Wang Ruibing¹,Chen Xiaoyuan³^ORCID

Affiliation:

1. State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Avenida da Universidade Taipa Macau 999078 P. R. China

2. Laboratory of Molecular Imaging and Nanomedicine National Institute of Biomedical Imaging and Bioengineering National Institutes of Health Bethesda Bethesda MD 20892 USA

3. Yong Loo Lin School of Medicine Faculty of Engineering National University of Singapore Singapore 119228 Singapore

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adfm.202008078

Reference38 articles.

1. Cancer immunotherapy using checkpoint blockade

2. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy